Barbero Cristina, Ricci Davide, Cura Stura Erik, Pellegrini Augusto, Marchetto Giovanni, ElQarra Suad, Boffini Massimo, Passera Roberto, Valentini Maria Consuelo, Rinaldi Mauro
Department of Cardiovascular and Thoracic Surgery, University of Turin, Corso Bramante 88, 10126, Turin, Italy.
Department of Nuclear Medicine, University of Turin, Turin, Italy.
Trials. 2017 Feb 21;18(1):76. doi: 10.1186/s13063-017-1821-y.
Recent data have highlighted a higher rate of neurological injuries in minimal invasive mitral valve surgery (MIMVS) compared with the standard sternotomy approach; therefore, the role of specific clamping techniques and perfusion strategies on the occurrence of this complication is a matter of discussion in the medical literature. The purpose of this trial is to prospectively evaluate major, minor and silent neurological events in patients undergoing right mini-thoracotomy mitral valve surgery using retrograde perfusion and an endoaortic clamp or a transthoracic clamp.
METHODS/DESIGN: A prospective, blinded, randomized controlled study on the rate of neurological embolizations during MIMVS started at the University of Turin in June 2014. Major, minor and silent neurological events are being investigated through standard neurological evaluation and magnetic resonance imaging assessment. The magnetic resonance imaging protocol includes conventional sequences for the morphological and quantitative assessment and nonconventional sequences for the white matter microstructural evaluation. Imaging studies are performed before surgery as baseline assessment and on the third postoperative day and, in patients who develop postoperative ischemic lesions, after 6 months.
Despite recent concerns raised about the endoaortic setting with retrograde perfusion, we expect to show equivalence in terms of neurological events of this technique compared with the transthoracic clamp in a selected cohort of patients. With the first results expected in December 2016 the findings would be of help in confirming the efficacy and safety of MIMVS.
ClinicalTrials.gov, Identifier: NCT02818166 . Registered on 8 February 2016 - trial retrospectively registered.
最近的数据显示,与标准胸骨切开术相比,微创二尖瓣手术(MIMVS)中神经损伤的发生率更高;因此,特定的钳夹技术和灌注策略对这种并发症发生的作用在医学文献中是一个讨论的话题。本试验的目的是前瞻性评估接受右胸小切口二尖瓣手术的患者,采用逆行灌注和主动脉内钳夹或经胸钳夹时发生的主要、次要和无症状神经事件。
方法/设计:2014年6月在都灵大学启动了一项关于MIMVS期间神经栓塞发生率的前瞻性、盲法、随机对照研究。通过标准神经评估和磁共振成像评估来调查主要、次要和无症状神经事件。磁共振成像方案包括用于形态学和定量评估的常规序列以及用于白质微观结构评估的非常规序列。成像研究在手术前作为基线评估进行,在术后第三天进行,对于发生术后缺血性病变的患者,在术后6个月进行。
尽管最近人们对逆行灌注的主动脉内设置提出了担忧,但我们预计在选定的患者队列中,该技术在神经事件方面与经胸钳夹相当。预计2016年12月得出初步结果,这些结果将有助于证实MIMVS的有效性和安全性。
ClinicalTrials.gov,标识符:NCT02818166。于2016年2月8日注册——试验为回顾性注册。